STSS: sharpstechnology.com Company Buyout Price

Official company branding of sharpstechnology.com (STSS)

The price action of Sharps Technology, Inc. (STSS) reflects a situation where revenue deficits and a rapid cash burn have created survival risks, necessitating stringent management. The indicator stands at 65.15. The business relies on smart injection systems that are difficult to replace due to their deep integration into hospital protocols; however, its status as a mass-market consumable prevents the company from exercising pricing power over hospital networks.

STSS (Sharps Technology, Inc.) Total Company Value history from 11/23/2025 to 05/28/2026

STSS (Sharps Technology): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Sharps Technology Inc|STSS - Price Target Chart
- market capitalization data:
Market Capitalization Sharps Technology, Inc.|STSS - Total Company Value
- book capitalization data:
Net Assets per Share Sharps Technology, Inc.|STSS - Company Book Value|Market Cap to Net Assets Ratio sharpstechnology.com|STSS - Company Total Assets
- debt and liquidity data:
Debt to Capital Sharps Technology, Inc.|STSS - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Sharps Technology Inc|STSS - Company Aggregate Debts|Debts to Net Assets Sharps Technology, Inc.
General company analysis:STSS (Sharps Technology, Inc.)
Original product of Sharps Technology, Inc.

The integration of Sharps Technology, Inc. (STSS) security systems into pharmaceutical syringes through strategic partnerships forms the foundation of the company's asset value. Analyzing the enterprise value chart, an investor can see the actual buyout price of the issuer, calculated as the sum of market capitalization and net debt, which allows for an assessment of the company's scale beyond simple stock quotes and the identification of hidden liquidity risks.

Competitor analysis for Sharps Technology, Inc.

Intuitive Surgical, Inc. - Aggregate Business Value|Total Company Value DHR (Danaher Corp)|BDX: Company Buyout Price|STERIS plc - Total Company Value|WST (westpharma.com) - Company Buyout Price|Total Company Value BAX|Real Price to Acquire Entire Company Masimo Corp|Stevanato - Enterprise Value|Total Enterprise Value Teleflex Corp (TFX)|MMSI - Enterprise Value|Business Value envistaco.com NVST|Enterprise Value ICUI (ICU Medical)|XRAY - Company Buyout Price|LMAT (LeMaitre) - Enterprise Value|AtriCure Medical (ATRC) - Real Price to Acquire Entire Company|STAA (STAAR Surgical Company) - Enterprise Value|Enterprise Value NAGE|Total Company Value ZimVie (ZIMV)|Total Company Value AngioDynamics Inc ANGO|Real Price to Acquire Entire Company Cerus Corp|Value Adjusted for Debt and Cash Teknova Inc TKNO|Enterprise Value MGRM (Monogram Technologies)|INFU: Company Buyout Price|Total Company Value Utah Medical Products, Inc.|KRMD (KORU Medical) - Business Value|NYXH: Total Company Value|Company Buyout Price Microbot Medical, Inc (MBOT)|Real Price to Acquire Entire Company Pro-Dex, Inc.|Aggregate Business Value ZTEK (zentek.com)|Total Company Value Elutia|MLSS - Value Adjusted for Debt and Cash|NEXGEL, Inc - Real Price to Acquire Entire Company|RVP: Enterprise Value|HBIO (Harvard Bioscience) - Total Company Value|femasys.com (FEMY) - Real Price to Acquire Entire Company|Enterprise Value MHUA (Meihua Medical Technologies)|Total Enterprise Value POAI|Total Company Value Callan JMB Inc CJMB|Business Value Atrion Corporation Inc. ATRI|Real Price to Acquire Entire Company NeuroMetrix, Inc. (NURO)